Researchers found that Smith+Nephew’s TESSA Spatial Surgery System has received De Novo classification from the FDA, marking a significant advancement in sports medicine. This innovative system utilizes artificial intelligence and augmented reality to enhance the precision of arthroscopic surgeries, particularly for knee ligament reconstruction. By creating patient-specific 3D anatomical models from preoperative scans, the TESSA System helps surgeons visualize and navigate during procedures, potentially improving outcomes for patients.

This breakthrough could be especially relevant for individuals facing knee surgeries, as the TESSA System addresses common issues like misplacement of surgical tunnels, which can lead to complications and failed surgeries. The technology aims to improve the accuracy of procedures like anterior cruciate ligament (ACL) reconstruction, a common surgery among athletes and active individuals. With femoral malposition occurring in nearly 29% of cases, the TESSA System could significantly enhance surgical success rates and recovery times.

Currently, the TESSA System is in the early stages of implementation, with commercial availability expected in late 2026. While the FDA’s approval is a promising step, the technology’s long-term effectiveness in real-world settings remains to be fully validated. As it stands, the TESSA System represents a new category of orthopedic navigation tools, but further studies will be necessary to establish its impact on surgical outcomes.

For those interested in the latest advancements in surgical technology, staying informed about the TESSA System’s rollout could be beneficial. While it may not be available yet, understanding how such innovations can improve surgical precision may empower you to make informed decisions about your health and treatment options in the future.

Source